Bortezomib-combination based therapy in relapsed-refractory myeloma patients. Hematol Meeting Rep [Internet]. 2009 Jun. 8 [cited 2025 Jul. 4];2(5). Available from: https://journals.pagepress.org/hmr/article/view/381